| Sandoz Pharmaceuticals AG - Lisitril 5, Tabletten |
| 56061 | | 01 | | Lisitril 5 | | Tabletten | | C09AA03 | | Lisinopril | | 02.09.2003 | | |
|
| Composition |
| lisinoprilum 5 mg ut lisinoprilum dihydricum, calcii hydrogenophosphas dihydricus, mannitolum, maydis amylum, carmellosum natricum conexum corresp. natrium 0.18 mg, magnesii stearas, E 172 (rubrum), pro compresso. |
| Packungsbestandteile |
| Tablets | | | | | Active Agent | Dose |
|---|
| Lisinopril | 5 mg |
| | BAG: Active Agent | Dose |
|---|
| Lisinopril | 5 mg |
| | | | Inactive agents | | additional_information |
|---|
| | | | | Calcium Hydrogen Phosphate Dihydrate | | | | | | | | | | color. | | | | | | Mannitol | | | | | | | | | | |
| |
|
| Teilbarkeit |
| | Ja | | | | Ja (innert 5-15 min in 30 ml Wasser) | | | | Ja | | | | -- | | | | Sondenapplikation: Tablette mörsern und in 10 ml Wasser suspendieren, gut ausspülen | | | | | |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 30 Tablet(s) | 2.53 | 12.00 | B | SL | No | | 004 | 100 Tablet(s) | 6.25 | 16.05 | B | SL | No |
|
